Absci

Abscis is a generative AI drug creation company that combines AI with wet lab technologies. Absci is dedicated to expediting the development of improved biologics for patients. Abscis’ integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company’s products include solutions that enable the rapid identification of potential targets and the design of optimized antibody candidates.